Twitxy Saved

Kelly Bolton MD PhD

@KellyLBolton

Mom, Physician, Scientist at Washington University in St Louis
St Louis, MO Joined March 2019
418 Following 761 Followers 883 Posts

Latest posts 5

Pinned post

Kelly Bolton MD PhD @KellyLBolton
Chemotherapy and ionizing radiation are known to promote clonal hematopoiesis and its progression to leukemia. By inducing temporary quiescence of hematopoietic stem cells during external stress might we mitigate CH expansion? We address this through a collaboration with @AbdelWahablab @PuZhang09980432: nature.com/articles/s4158…. Excited to share this and some thoughts from a recent meeting in Hiroshima which puts this work in a broader perspective.
www.nature.com CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis Nature Genetics - Analysis of clinical trial data suggests that CDK4/6 inhibitors prevent the expansion of TP53-mutant clones in the blood, potentially mitigating the risk of secondary myeloid...
6 replies 28 reposts 95 likes 5.7K views View on X
Kelly Bolton MD PhD @KellyLBolton
Thank you for inviting me @WaxmanCancer it’s been a fantastic meeting!!
Waxman Institute @WaxmanCancer Oct 19
At the #2026agingcancermeeting at @jacksonlab - @KellyLBolton, of @washumedicine explores the links btwn aging, clonal hematopoiesis (the growth of blood cells carrying acquired genetic changes) & myelodysplastic syndromes w/ @TheMarkFdn
View quoted post on X
Kelly Bolton MD PhD @KellyLBolton
Totally agree Callie. So for a chemoprevention agent you need a placebo controlled RCT to get FDA approval but for a MCP you need basically only to show you aren’t hurting people? Maybe not even that?
calliecoombs @calliecoombsmd Oct 9
Not to detract from the great things this test can/may do, I do have a genuine worry about possible harm from increased procedures/complications that may result. I hope we can strike the right balance for our pts.
View quoted post on X
1 replies 0 reposts 13 likes 456 views View on X
Kelly Bolton MD PhD @KellyLBolton
Nothing ready for clinical practice yet but yes. I think testing pre and during treatment for certain therapies might be something we do in the future. We and others are studying potential ways to protect the marrow. Also could influence treatment decisions.
Kopi C Kosong Verified account @powermakeup69 Oct 4
@KellyLBolton @NatureGenet Hi, thanks for sharing. Do you see a future where CH NGS monitoring test is included as part of the post treatment monitoring?
View quoted post on X